Dr. Becher and the NOAH—AFNET 6 team evaluated the efficacy and safety of anticoagulation with edoxaban in patients with long episodes of device-detected atrial fibrillation lasting 24 hours or ...

More information: Paulus Kirchhof et al, Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials ...

Atrial fibrillation (AF) is the most common cardiac arrhythmia, and its incidence increases with age. Current data suggest that anticoagulation with warfarin or dabigatran is far superior to ...

The annual risk of recurrent ischemic stroke in patients with atrial fibrillation (AF) is about 3.75%, despite around 92% of ...

In this randomized trial, left atrial appendage closure was associated with lower bleeding than oral anticoagulation in patients who underwent catheter-based atrial fibrillation ablation. 2. Left ...

Objective: To evaluate data addressing use of anticoagulation in elderly patients with atrial fibrillation (AF), in particular those at risk of falls. Data Sources: Primary literature was ...

If you have atrial fibrillation (AFib), your doctor may suggest long-term blood thinners, also called anticoagulants. They lower your risk for stroke caused by a blood clot, the most dangerous ...

Warfarin reduces the risk of stroke in atrial fibrillation by around 60%, while antiplatelet therapy is much less effective. Bleeding is, however, a notable adverse effect with warfarin.

I've been diagnosed with atrial fibrillation. I've read that it puts me at greater risk of stroke. Can you tell me more about ...

Data show early anticoagulation after acute stroke in people with atrial fibrillation is safe when indicated. Risk for recurrent ischemic stroke at 30 days was lower in the early vs. late ...

The American Heart Association estimates that atrial fibrillation (AF ... requires a balance between the risks and benefits of oral anticoagulation therapy. Individualized selection of an ...